High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models
[ad_1] Starting in his early teens, Deshawn “DJ” Chow wasn’t sure he’d ever be able to live a normal life. Crushing pain episodes brought on by his sickle cell disease were getting progressively worse. “It’s just been hard skipping school and always being in and out of the hospital,” the 19-year-old said. “And just … Read more
